To further confirm whether the anti-obesity effect of artesunate is mediated by the GDF15/GFRAL axis, we quantified the percentage abundance of active c-Fos+ neurons within the AP, following a bolus intraperitoneal dose of artesunate. This evidence concerns the gene FOS and obesity disorder.